Correction to Lancet Neurol 2018; 17: 939–53 (The Lancet Neurology (2018) 17(11) (939–953), (S1474442218302953), (10.1016/S1474-4422(18)30295-3));Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

The Lancet Neurology

Volumn 17, Issue 11, 2018, Pages 939-953

  Ray Dorsey, E ^a   Elbaz, Alexis ^b   Nichols, Emma ^c   Abd Allah, Foad ^d   Abdelalim, Ahmed ^d   Adsuar, Jose C ^e   Ansha, Mustafa Geleto ^f   Brayne, Carol ^g   Choi, Jee Young J ^h   Collado Mateo, Daniel ^e,i   Dahodwala, Nabila ^j   Do, Huyen Phuc ^k   Edessa, Dumessa ^l   Endres, Matthias ^m   Fereshtehnejad, Seyed Mohammad ^n,o   Foreman, Kyle J ^c,p   Gankpe, Fortune Gbetoho ^q,r   Gupta, Rahul ^s,t   Hankey, Graeme J ^u   Hay, Simon I ^c   Hegazy, Mohamed I ^d   Hibstu, Desalegn T ^v   Kasaeian, Amir ^w   Khader, Yousef ^x   Khalil, Ibrahim ^c   Khang, Young Ho ^y   Kim, Yun Jin ^z   Kokubo, Yoshihiro ^aa   Logroscino, Giancarlo ^ab   Massano, João ^ac   Ibrahim, Norlinah Mohamed ^ae   Mohammed, Mohammed A ^af,ag   Mohammadi, Alireza ^ah   Moradi Lakeh, Maziar ^ai   Naghavi, Mohsen ^c   Nguyen, Binh Thanh ^k   Nirayo, Yirga Legesse ^aj   Ogbo, Felix Akpojene ^ak   Owolabi, Mayowa Ojo ^al   Pereira, David M ^ad   Postma, Maarten J ^am   Qorbani, Mostafa ^an   Rahman, Muhammad Aziz ^ao,ap   Roba, Kedir T ^l   Safari, Hosein ^aq   Safiri, Saeid ^ar   Satpathy, Maheswar ^as   Sawhney, Monika ^at   Shafieesabet, Azadeh ^au   Shiferaw, Mekonnen Sisay ^l   Smith, Mari ^c   Szoeke, Cassandra E I ^av   Tabarés Seisdedos, Rafael ^ax   Truong, Nu Thi ^k   Ukwaja, Kingsley Nnanna ^ay   Venketasubramanian, Narayanaswamy ^az,ba   Villafaina, Santos ^e   Weldegwergs, Kidu Gidey ^aj   Westerman, Ronny ^bb   Wijeratne, Tissa ^ao,aw   Winkler, Andrea S ^bc,bd   Xuan, Bach Tran ^be   Yonemoto, Naohiro ^bf   Feigin, Valery L ^bg   Vos, Theo ^c   Murray, Christopher J L ^c   more..

^a UNIVERSITY OF ROCHESTER   (United States)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CAIRO UNIVERSITY   (Egypt)

^e UNIVERSITY OF EXTREMADURA   (Spain)

^f DEBRE BERHAN UNIVERSITY   (Ethiopia)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h Seoul National University Hospital   (South Korea)

ⁱ UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k DUY TAN UNIVERSITY   (Viet Nam)

^l HARAMAYA UNIVERSITY   (Ethiopia)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ MCGILL UNIVERSITY   (Canada)

^o KAROLINSKA INSTITUTE   (Sweden)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q SIDI MOHAMED BEN ABDELLAH UNIVERSITY   (Morocco)

^r Laboratoire d Etudes et de Recherche action en Santé   (Benin)

^s West Virginia Bureau for Public Health   (United States)

^t WEST VIRGINIA UNIVERSITY   (United States)

^u UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^v HAWASSA UNIVERSITY   (Ethiopia)

^w TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^x JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^y Seoul National University College of Medicine   (South Korea)

^z Xiamen University   (Malaysia)

^aa NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^ab UNIVERSITY OF BARI   (Italy)

^ac University of Porto   (Portugal)

^ad UNIVERSITY OF PORTO   (Portugal)

^ae UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^af JIGJIGA UNIVERSITY   (Ethiopia)

^ag UNIVERSITY OF SYDNEY   (Australia)

^ah BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ai IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^aj MEKELLE UNIVERSITY   (Ethiopia)

^ak UNIVERSITY OF WESTERN SYDNEY   (Australia)

^al UNIVERSITY OF IBADAN   (Nigeria)

^am UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^an ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ao LA TROBE UNIVERSITY   (Australia)

^ap DEAKIN UNIVERSITY   (Australia)

^aq AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ar MARAGHEH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^as UTKAL UNIVERSITY   (India)

^at UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^au NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^av UNIVERSITY OF MELBOURNE   (Australia)

^aw UNIVERSITY OF MELBOURNE   (Australia)

^ax UNIVERSITY OF VALENCIA   (Spain)

^ay FEDERAL TEACHING HOSPITAL   (Nigeria)

^az RAFFLES HOSPITAL   (Singapore)

^ba NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^bb FEDERAL INSTITUTE FOR POPULATION RESEARCH   (Germany)

^bc TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^bd UNIVERSITY OF OSLO   (Norway)

^be HANOI MEDICAL UNIVERSITY   (Viet Nam)

^bf KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^bg AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISABILITY; DISABILITY-ADJUSTED LIFE YEAR; DISEASE DURATION; ENVIRONMENTAL FACTOR; FEMALE; FERTILITY; GLOBAL DISEASE BURDEN; HOEHN AND YAHR SCALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; VERY ELDERLY; DISABLED PERSON; ECONOMICS; GLOBAL HEALTH; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDY; PROCEDURES; RISK ASSESSMENT;

DISABLED PERSONS; FEMALE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; PARKINSON DISEASE; PREVALENCE; RISK ASSESSMENT;

EID: 85055021376     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(21)00382-3     Document Type: Erratum

References (47)

1. GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16 (2017), 877–897.
2. de Lau, LM, Breteler, MM, Epidemiology of Parkinson's disease. Lancet Neurol 5 (2006), 525–535.
3. Pringsheim, T, Jette, N, Frolkis, A, Steeves, TD, The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord 29 (2014), 1583–1590.
4. Muangpaisan, W, Mathews, A, Hori, H, Seidel, D, A systematic review of the worldwide prevalence and incidence of Parkinson's disease. J Med Assoc Thai 94 (2011), 749–755.
5. Bellou, V, Belbasis, L, Tzoulaki, I, Evangelou, E, Ioannidis, JP, Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord 23 (2016), 1–9.
6. Harris, R, Epidemiology of Parkinson's disease. Epidemiology of chronic diseases, 2012, Jones & Bartlett Learning, Burlington, MA, 587–602.
7. Pezzoli, G, Cereda, E, Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 80 (2013), 2035–2041.
8. Weisskopf, MG, Weuve, J, Nie, H, et al. Association of cumulative lead exposure with Parkinson's disease. Environ Health Perspect 118 (2010), 1609–1613.
9. Vlaar, T, Kab, S, Schwaab, Y, Frery, N, Elbaz, A, Moisan, F, Association of Parkinson's disease with industry sectors: a French nationwide incidence study. Eur J Epidemiol, 2018 published online May 5. DOI:10.1007/s10654-018-0399-3.
10. Li, X, Li, W, Liu, G, Shen, X, Tang, Y, Association between cigarette smoking and Parkinson's disease: a meta-analysis. Arch Gerontol Geriatr 61 (2015), 510–516.
11. Ritz, B, Lee, PC, Lassen, CF, Arah, OA, Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. Neurology 83 (2014), 1396–1402.
12. Wanneveich, M, Moisan, F, Jacqmin-Gadda, H, Elbaz, A, Joly, P, Projections of prevalence, lifetime risk and life expectancy of Parkinson disease (2010–2030) in France. Mov Disord, 2018 published online Aug 25. DOI:10.1002/mds.27447.
13. Dorsey, ER, Constantinescu, R, Thompson, JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68 (2007), 384–386.
14. Rossi, A, Berger, K, Chen, H, Leslie, D, Mailman, RB, Huang, X, Projection of the prevalence of Parkinson's disease in the coming decades: revisited. Mov Disord 33 (2018), 156–159.
15. GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1084–1150.
16. Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992), 181–184.
17. GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet 390 (2017), 231–266.
18. Hoehn, MM, Yahr, MD, Parkinsonism: onset, progression and mortality. Neurology 17 (1967), 427–442.
19. Goetz, CG, Poewe, W, Rascol, O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19 (2004), 1020–1028.
20. Salomon, JA, Haagsma, JA, Davis, A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 3 (2015), e712–e723.
21. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1345–1422.
22. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1151–1210.
23. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
24. Rizzo, G, Copetti, M, Arcuti, S, Martino, D, Fontana, A, Logroscino, G, Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86 (2016), 566–576.
25. Anderson, DW, Rocca, WA, de Rijk, MC, et al. Case ascertainment uncertainties in prevalence surveys of Parkinson's disease. Mov Disord 13 (1998), 626–632.
26. Macleod, AD, Taylor, KS, Counsell, CE, Mortality in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 29 (2014), 1615–1622.
27. Marmot, M, The influence of income on health: views of an epidemiologist. Health Aff (Millwood) 21 (2002), 31–46.
28. Bloom, DE, Canning, D, Policy forum: public health. The health and wealth of nations. Science 287 (2000), 1207–1209.
29. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 388 (2016), 1813–1850.
30. Savica, R, Grossardt, BR, Bower, JH, Ahlskog, JE, Rocca, WA, Time trends in the incidence of Parkinson disease. JAMA Neurol 73 (2016), 981–989.
31. Darweesh, SK, Koudstaal, PJ, Stricker, BH, Hofman, A, Ikram, MA, Trends in the incidence of Parkinson disease in the general population: the Rotterdam Study. Am J Epidemiol 183 (2016), 1018–1026.
32. Lix, LM, Hobson, DE, Azimaee, M, Leslie, WD, Burchill, C, Hobson, S, Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis. J Epidemiol Community Health 64 (2010), 335–340.
33. Akushevich, I, Kravchenko, J, Ukraintseva, S, Arbeev, K, Yashin, AI, Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. Age Ageing 42 (2013), 494–500.
34. Isotalo, J, Vahlberg, T, Kaasinen, V, Unchanged long-term rural-to-urban incidence ratio of Parkinson's disease. Mov Disord 32 (2017), 474–475.
35. Ng, M, Freeman, MK, Fleming, TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA 311 (2014), 183–192.
36. Savica, R, Rocca, WA, Ahlskog, JE, When does Parkinson disease start?. Arch Neurol 67 (2010), 798–801.
37. Gardner, RC, Byers, AL, Barnes, DE, Li, Y, Boscardin, J, Yaffe, K, Mild TBI and risk of Parkinson disease: a Chronic Effects of Neurotrauma Consortium study. Neurology 90 (2018), e1771–e1779.
38. von Campenhausen, S, Bornschein, B, Wick, R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 15 (2005), 473–490.
39. Paulson, GW, Gill, WM, Are death certificates reliable to estimate the incidence of Parkinson's disease?. Mov Disord, 10, 1995, 678.
40. Phillips, NJ, Reay, J, Martyn, CN, Validity of mortality data for Parkinson's disease. J Epidemiology Community Health 53 (1999), 587–588.
41. Elbaz, A, Bower, JH, Peterson, BJ, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 60 (2003), 91–96.
42. Pressley, JC, Tang, MX, Marder, K, Cote, LJ, Mayeux, R, Disparities in the recording of Parkinson's disease on death certificates. Mov Disord 20 (2005), 315–321.
43. Benito-Leon, J, Louis, ED, Villarejo-Galende, A, Romero, JP, Bermejo-Pareja, F, Under-reporting of Parkinson's disease on death certificates: a population-based study (NEDICES). J Neurol Sci 347 (2014), 188–192.
44. Galea, S, Tracy, M, Participation rates in epidemiologic studies. Ann Epidemiol 17 (2007), 643–653.
45. Bach, JP, Ziegler, U, Deuschl, G, Dodel, R, Doblhammer-Reiter, G, Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord 26 (2011), 2286–2290.
46. Dorsey, ER, Bloem, BR, The Parkinson pandemic—a call to action. JAMA Neurol 75 (2017), 9–10.
47. Tanner, CM, Comella, CL, When brawn benefits brain: physical activity and Parkinson's disease risk. Brain 138 (2015), 238–239.